Breyanzi car t cell therapy
Ended Awarded Last action
- Contract number
- 36C24926N0286
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $335,043
Award facts
- Contract value 100% obligated
- $335,042.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrenceville, Lawrence Township, NJ 08648, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $335,042.65 by Veterans Integrated Service Network 9 (VISN 9), a civilian component of the Department of Veterans Affairs, for the supply of BREYANZI CAR T cell therapy. This firm fixed-price delivery order, awarded on January 21, 2026, with an ultimate completion date of April 30, 2026, represents a child contract issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which carries a substantial ceiling value of $12.3 billion through April 2029. The product will be delivered to the company's manufacturing facility in Lawrenceville, New Jersey. No set-aside designation was applied to this award, reflecting Bristol-Myers Squibb's status as a large pharmaceutical manufacturer.
BREYANZI is an innovative chimeric antigen receptor (CAR) T cell immunotherapy used to treat hematologic malignancies, including non-Hodgkin lymphoma and other blood cancers. This delivery order supports the VA's mission to provide advanced oncology treatments to eligible veterans through its established pharmaceutical supply chain. Bristol-Myers Squibb has been a consistent federal contractor for specialized cell therapies, with multiple similar delivery orders awarded across various VISNs, underscoring the company's critical role in supplying cutting-edge cancer treatments to the federal healthcare system.
Quick answers
Who was awarded contract 36C24926N0286?
36C24926N0286 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on January 21, 2026.
How much is contract 36C24926N0286 worth?
The government has obligated $335,043 on 36C24926N0286.
Is contract 36C24926N0286 an order under another contract?
Yes. 36C24926N0286 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926N0286 competed?
The extent of competition for 36C24926N0286 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award